Lindsey Mashburn, MD
Obstetrics & Gynecology · Cornelius, NCNPI 1770762007
Payments from drug & device makers
Across 148 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exeltis, USA Inc.$723
- AbbVie$436
- Merz North America, Inc.$266
- Galderma Laboratories, L.p.$196
- Takeda Pharmaceuticals U.S.A., Inc.$153
- Astellas Pharma US Inc$132
- plus $643 from 17 others
What the payments were for
- Speaking & faculty fees$1506%
- Food & beverage$2,23288%
- Education$1677%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exeltis, USA Inc. | 51 | $723 |
| AbbVie(2 entities) | 31 | $436 |
| Merz North America, Inc. | 6 | $266 |
| Galderma Laboratories, L.p. | 4 | $196 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $153 |
| Astellas Pharma US Inc | 5 | $132 |
| Currax Pharmaceuticals LLC | 7 | $96 |
| AMAG Pharmaceuticals, Inc. | 7 | $87 |
| Pfizer | 4 | $63 |
| Therapeuticsmd, Inc. | 4 | $62 |
| Biohaven Pharmaceuticals, Inc. | 4 | $57 |
| Organon | 3 | $50 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $49 |
| Mylan Pharmaceuticals Inc. | 2 | $40 |
| Mayne Pharma Commercial LLC | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $18 |
| Merck | 1 | $15 |
| Ascend Therapeutics US, LLC | 1 | $14 |
| Shire North American Group Inc | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Olympus America Inc. | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
| Avion Pharmaceuticals | 1 | $11 |
How this compares
$2,549 in reported general payments places this provider in the 80th percentile of 1,344 obstetrics & gynecology providers in North Carolina.
See all obstetrics & gynecology providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 17 | $2,023 |
| ProgesteroneProgesterone, Micronized | 58 | $1,977 |
| Estradiol | 22 | $916 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Cornelius
- Laura McKainWilmington$2.6M
- Robert ParkerWinston-Salem$2.1M
- Allison PuechlCharlotte$1.6M
- Jeffrey MichelsonNew Bern$1.2M
- Robert LittletonRaleigh$976K
- Donald HornerCharlotte$907K
- Rebecca Dunsmoor SuMorrisville$837K
- Ann CollinsRaleigh$701K
- Kathryn PattenHendersonville$550K
- Mohamad Mehdi ParvaElizabeth City$538K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.